应用引导的高级心脏生命支持算法对模拟院内心脏骤停中团队合作、非技术技能和工作负荷的影响:一项随机对照可行性试验
该前瞻性随机模拟可行性试验纳入40个跨专业两人团队(80名参与者),1:1随机比较使用CPR Leader应用与不使用该应用在标准化院内心脏骤停场景(心搏停止与心室颤动)中的表现。主要结局为团队表现(TEAM)、非技术技能(ANTS)和主观工作负荷(NASA-TLX)。结果显示NASA-TLX总分两组均高但可比(应用组平均49.2±13.6 vs 对照组54.1±14.6;p=0.2),应用组努力程度更高而对照组挫败感更高;TEAM与ANTS评分无组间有意义差异;除心室颤动场景中对照组胸外按压启动更早外,节律分析、除颤、给药和胸外按压质量等复苏指标两组相似。作者认为这些发现可能反映参与者临床经验水平高,不应推广至新手提供者、混合经验团队、院前环境或培训环境。
要点
- 在40个两人团队(80名参与者)的模拟院内心脏骤停中,使用CPR Leader应用未较标准实践明确改善指南推荐ALS算法的依从性或复苏表现。
- NASA-TLX总分两组均高但可比:应用组平均49.2±13.6 vs 对照组54.1±14.6(p=0.2),应用组报告努力程度更高,对照组挫败感更高。
- TEAM与ANTS评分无组间有意义差异。
- 节律分析、除颤、给药和胸外按压质量两组相似,唯一例外是心室颤动场景中对照组胸外按压启动更早。
- 作者认为发现可能反映参与者临床经验水平高,不应推广至新手提供者、混合经验团队、院前环境或培训环境。
适用人群与场景
- 以经验丰富的院内医护人员为主的跨专业两人团队,参与模拟院内心脏骤停场景(心搏停止与心室颤动)。
- 作者指出不应将结果推广至新手提供者、混合经验团队、院前环境或培训环境。
研究设计与关键结果
- 研究类型:前瞻性、随机、基于模拟的对照可行性试验;40个跨专业两人团队(80名参与者),1:1随机分为干预组(使用CPR Leader应用)与对照组。
- 主要结局:团队表现(TEAM)、非技术技能(ANTS)、主观工作负荷(NASA-TLX);NASA-TLX总分应用组平均49.2±13.6 vs 对照组54.1±14.6(p=0.2),应用组努力程度更高,对照组挫败感更高。
- TEAM与ANTS评分无组间有意义差异。
- 次要结局:节律分析、除颤、给药、胸外按压质量等客观复苏指标两组相似;唯一例外为心室颤动场景中对照组胸外按压启动更早。
证据类型、等级与局限
- 证据类型:前瞻性随机模拟可行性试验(探索性)。
- 局限:作者指出这些发现可能反映参与者临床经验水平高,不应推广至新手提供者、混合经验团队、院前环境或培训环境;需进一步研究评估认知辅助工具在经验较少人群和真实临床实践中的潜在获益。
对床旁实践的改变
- 作者认为,在经验丰富的院内医护人员模拟院内心脏骤停中,CPR Leader应用未较标准实践明确改善指南推荐ALS算法的依从性或复苏表现,不应将结果推广至新手提供者、混合经验团队、院前环境或培训环境。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In-hospital cardiac arrest carries high mortality despite advances in monitoring, rapid response systems, and adherence to advanced life support (ALS) guidelines. Digital decision-support tools, including mobile applications, are increasingly explored to improve guideline adherence, yet their impact on cognitive workload, team performance, and ALS performance remains uncertain.
METHODS: We conducted a prospective, randomized, simulation-based controlled feasibility trial with 40 interprofessional teams (80 participants) comparing ALS performance with and without the use of the 'CPR Leader' app. Two-person teams were randomized 1:1 to intervention or control and followed standardized in-hospital cardiac arrest scenarios (asystole and ventricular fibrillation). Primary outcomes included team performance (TEAM), non-technical skills (ANTS), and subjective workload (NASA-TLX). Secondary outcomes comprised objective resuscitation metrics, including time to rhythm analysis, defibrillation, medication administration, and chest compression quality.
RESULTS: Overall NASA-TLX scores were high but comparable between intervention and control group (mean 49.2 ± 13.6 vs. 54.1 ± 14.6; p = 0.2), with higher effort reported in the app group and higher frustration in the control group. TEAM and ANTS scores showed no evidence of meaningful between-group differences. Across the two scenarios types, ALS performance metrics-including rhythm analysis, defibrillation, medication administration, and chest compression quality-were similar between groups, with the exception of earlier chest compression initiation in the control group during ventricular fibrillation.
CONCLUSIONS: In this exploratory randomized simulation study involving predominantly experienced in-hospital healthcare professionals, the use of a resuscitation support application did not demonstrate a clear improvement in adherence to guideline-recommended ALS algorithms or resuscitation performance compared with standard practice. These findings likely reflect the high level of participants' clinical experience and should not be generalized to novice providers, mixed-experience teams, prehospital settings, or training environments. Further studies are warranted to evaluate the potential benefits of cognitive aids in less experienced populations and in real-world clinical practice.
参考来源
- Kamphausen A, Pilz M, Baumgärtel M, et al. Effect of an app-guided advanced cardiac life support algorithm on teamwork, non-technical skills, and workload in simulated in-hospital cardiac arrest: a randomized controlled feasibility trial. Scand J Trauma Resusc Emerg Med. 2026. PMID: 42596010. doi:10.1186/s13049-026-01673-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。